应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
VIVS VivoSim Lab, Inc.
盘前交易 02-05 05:02:10 EST
2.35
-0.40
-14.55%
盘前
2.31
-0.04
-1.70%
04:08 EST
最高
2.89
最低
2.34
成交量
38.22万
今开
2.67
昨收
2.75
日振幅
20.00%
总市值
610.95万
流通市值
604.42万
总股本
259.98万
成交额
102.51万
换手率
14.86%
流通股本
257.20万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
VivoSim Lab, Inc. 通过韩国和中国新分销协议扩大Namkind™人源毒理学服务在亚太地区的可及性
美股速递 · 01-30
VivoSim Lab, Inc. 通过韩国和中国新分销协议扩大Namkind™人源毒理学服务在亚太地区的可及性
Vivosim Labs, Inc.盘中异动 大幅下跌8.35%
市场透视 · 01-09
Vivosim Labs, Inc.盘中异动 大幅下跌8.35%
Vivosim Labs, Inc.盘中异动 早盘股价大涨7.31%
市场透视 · 2025-11-28
Vivosim Labs, Inc.盘中异动 早盘股价大涨7.31%
加载更多
公司概况
公司名称:
VivoSim Lab, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
VivoSim Labs, Inc.成立于2007年,从事开发和商业化可以应用在药物发现和开发,进行生物学研究,作为植入受损或退化组织和器官的治疗的人体组织技术平台。VivoSim计划引进到三维人体组织,通过构建三维创作,复制天然人类生物学的潜力。
发行价格:
--
{"stockData":{"symbol":"VIVS","market":"US","secType":"STK","nameCN":"VivoSim Lab, Inc.","latestPrice":2.35,"timestamp":1770238800000,"preClose":2.75,"halted":0,"volume":382170,"hourTrading":{"tag":"盘前","latestPrice":2.31,"preClose":2.35,"latestTime":"04:08 EST","volume":107,"amount":247.17000000000002,"timestamp":1770282520178,"change":-0.04,"changeRate":-0.017021,"amplitude":0},"delay":0,"changeRate":-0.14545454545454542,"floatShares":2572005,"shares":2599794,"eps":-0.7603638,"marketStatus":"盘前交易","change":-0.4,"latestTime":"02-05 05:02:10 EST","open":2.67,"high":2.89,"low":2.34,"amount":1025119.126314,"amplitude":0.2,"askPrice":2.6,"askSize":100,"bidPrice":2.33,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-0.7603638,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770301800000},"marketStatusCode":1,"adr":0,"listingDate":1373515200000,"exchange":"NASDAQ","adjPreClose":2.35,"preHourTrading":{"tag":"盘前","latestPrice":2.31,"preClose":2.35,"latestTime":"04:08 EST","volume":107,"amount":247.17000000000002,"timestamp":1770282520178,"change":-0.04,"changeRate":-0.017021,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":2.35,"preClose":2.35,"latestTime":"19:57 EST","volume":12171,"amount":29308.9264,"timestamp":1770253070637,"change":0,"changeRate":0,"amplitude":0.055319},"volumeRatio":0.019894976877748247},"requestUrl":"/m/hq/s/VIVS","defaultTab":"news","newsList":[{"id":"1134671302","title":"VivoSim Lab, Inc. 通过韩国和中国新分销协议扩大Namkind™人源毒理学服务在亚太地区的可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1134671302","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134671302?lang=zh_cn&edition=full","pubTime":"2026-01-30 05:08","pubTimestamp":1769720903,"startTime":"0","endTime":"0","summary":"VivoSim Lab, Inc. 近日宣布,公司已签署新的分销协议,旨在将旗下Namkind™人源毒理学服务更广泛地引入韩国和中国市场。此举标志着该公司在拓展亚太地区业务版图方面迈出了关键一步,旨在满足该区域日益增长的对先进、可靠毒理学测试方案的需求。\n通过此项战略合作,VivoSim Lab, Inc. 将借助当地分销伙伴的网络与专业优势,提升其创新服务的覆盖范围与市场渗透力。Namkind™技术平台以其基于人类生物学的独特测试模型而著称,有望为亚太地区的药物研发、化学品安全评估及相关生命科学领域提供更精准、更具预测性的人体反应数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VIVS"],"gpt_icon":0},{"id":"2602122803","title":"Vivosim Labs, Inc.盘中异动 大幅下跌8.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602122803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602122803?lang=zh_cn&edition=full","pubTime":"2026-01-09 01:55","pubTimestamp":1767894943,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日01时55分,Vivosim Labs, Inc.股票出现异动,股价大幅下挫8.35%。Vivosim Labs, Inc.股票所在的生物技术行业中,整体跌幅为0.93%。Vivosim Labs, Inc.公司简介:VivoSim Labs Inc前身为Organovo Holdings Inc,是一家生物技术公司,专注于开发FXR314治疗炎症性肠病,包括溃疡性结肠炎,基于三维人体组织的临床前景证明以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109015545a4acf44f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109015545a4acf44f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIVS","BK4139","IBD"],"gpt_icon":0},{"id":"2587075284","title":"Vivosim Labs, Inc.盘中异动 早盘股价大涨7.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2587075284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587075284?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:33","pubTimestamp":1764340392,"startTime":"0","endTime":"0","summary":"北京时间2025年11月28日22时33分,Vivosim Labs, Inc.股票出现波动,股价大幅上涨7.31%。Vivosim Labs, Inc.股票所在的生物技术行业中,整体跌幅为0.19%。Vivosim Labs, Inc.公司简介:VivoSim Labs Inc前身为Organovo Holdings Inc,是一家生物技术公司,专注于开发FXR314治疗炎症性肠病,包括溃疡性结肠炎,基于三维人体组织的临床前景证明以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128223312a4c0a7f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128223312a4c0a7f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VIVS","IBD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivosim.ai","stockEarnings":[{"period":"1week","weight":0.3584},{"period":"1month","weight":0.2051},{"period":"3month","weight":0.0731},{"period":"6month","weight":0.3467},{"period":"1year","weight":-0.4218},{"period":"ytd","weight":0.2983}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.0769},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.0063}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"VivoSim Labs, Inc.成立于2007年,从事开发和商业化可以应用在药物发现和开发,进行生物学研究,作为植入受损或退化组织和器官的治疗的人体组织技术平台。VivoSim计划引进到三维人体组织,通过构建三维创作,复制天然人类生物学的潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":-0.001588},{"month":2,"riseRate":0.538462,"avgChangeRate":0.076042},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.118072},{"month":4,"riseRate":0.5,"avgChangeRate":-0.007903},{"month":5,"riseRate":0.5,"avgChangeRate":0.055044},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.085299},{"month":7,"riseRate":0.333333,"avgChangeRate":0.012792},{"month":8,"riseRate":0.384615,"avgChangeRate":-0.076461},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.037473},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.055078},{"month":11,"riseRate":0.461538,"avgChangeRate":0.059307},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.024045}],"exchange":"NASDAQ","name":"VivoSim Lab, Inc.","nameEN":"VivoSim Lab, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VivoSim Lab, Inc.(VIVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供VivoSim Lab, Inc.(VIVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"VivoSim Lab, Inc.,VIVS,VivoSim Lab, Inc.股票,VivoSim Lab, Inc.股票老虎,VivoSim Lab, Inc.股票老虎国际,VivoSim Lab, Inc.行情,VivoSim Lab, Inc.股票行情,VivoSim Lab, Inc.股价,VivoSim Lab, Inc.股市,VivoSim Lab, Inc.股票价格,VivoSim Lab, Inc.股票交易,VivoSim Lab, Inc.股票购买,VivoSim Lab, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VivoSim Lab, Inc.(VIVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供VivoSim Lab, Inc.(VIVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}